Preliminary Program.

 
 
8:30AM Chair: ASSOC PROF HELEN EVANSNossal Institute for Global Health and Burnet Institute

8:30AM SIR RICHARD FEACHEM, University of California San Francisco
Challenges of Malaria Eradication

9:00AM DR RIMA SHRETTA, University of California San Francisco and APLMA
Economic case & political will for malaria elimination

9:30AM LUIS MORENO, President, Inter-American Development Bank and Member of End Malaria Council 
The Role of Global and Regional partnerships

10:00AM MORNING TEA & NETWORKING

10:30AM CONCURRENT 7
  Diagnostics development & the challenges of implementing new tools Expanding access to malaria interventionsThe Future of health financing Challenges to malaria eradication and how can we meet them?Innovative approaches to supporting affected persons voices to the table Accelerating Malaria R&D through international collaborations (sponsored by WIPO & BVGH)
  Chair: Dr Jane Cunningham, Global Malaria Programme, World Health Organisation
Chair: Dr Patricia GravesDr Helen Saxenian, Results for Development Chairs: Dr Ingrid Chen, University of California San FranciscoProf Maxine Whittaker, James Cook University

Chair: Ms Patricia Kelly, Director General, IP Australia
  Dr Gonzalo Domingo, Malaria Diagnostics Portfolio Lead, PATH Diagnostics
Diagnostics for Plasmodium vivax case management
  Dr Winnie Mpanju-Shumbusho, RBM Partnerships Mr Charles Randolph, Head, Global Health, World Intellectual Property Organisation
Introduction of World Intellectual Property Organisation and WIPO Re:Search
  Dr Sabine Dittrich, Head of Malaria & Fever, FIND Dr Helen Saxenian, Results for Development Dr Balbir Singh, University of Malaysia, Sarawak Ms Patricia Kelly, Director General, IP Australia
Introduction to IP Australia, the Australia government's global health vision, and the Australian FIT program
  Erin Nunan, Developing Countries Program Manager, Therapeutic Guidelines Limited - Tupaia Aparnaa Somanathan, World Bank Dr Corine Karema, University of Global Health Equity, Rwanda Dr Cathy Manner, Associate Director, BIO Ventures For Global Health
Introduction to FIT2 program, speakers, and session goal
  Amanda Chung, UCSF Malaria Elimination Initiative
Improving malaria service delivery & team performance in Southern Africa
Ferdinando Regalia - Inter-American Development Bank Dr Jim Tulloch, Chair, Technical Evaluation Reference Group, the Global Fund to Fight AIDS, Tuberculosis and Malaria Dr Rintis Noviyanti, Eijkman Institute for Molecular Biology, Indonesia
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Fellow perspective
  Dr George Okello, KEMRI-Wellcome Trust Research Programme
Producing malaria indicators through District Health Information Software (DHIS2): practices, processes and challenges in Kenya
Dr Rima Shretta, University of California San Francisco and APLMA
Transitions from donor financing & challenges for malaria elimination
Maelle Ba, Speak-up Africa
Create a sustained national commitment: both political and financial, for the elimination of malaria
Dr Alyssa Barry, Walter Eliza Hall Institute for Medical Research
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Host's perspective
  Discussion/Q&A Dr Susann Roth, Asian Development Bank Dr Helene Hiwat, National Malaria Control Program, Suriname - Malaria Champions of the Americas Dr Deus Ishengoma, National Institute for Medical Research (Tanzania)
Present research, FIT2 experience and skills learned, future plans post-sabbatical, and collaboration best practices - A Fellow perspective
    Dr Angela Micah, IHME (Institute for Health Metrics and Evaluation) Dr Taneshka Kruger, University of Pretoria
Innovation, education, communication and health promotion towards malaria elimination
Panel Session Moderated by Ms Amy Dietterich & Dr Cathy Manner
Panellists (Ms Patricia Kelly & FITC hosts & Fellows)
Topic: Discuss the challenges of R&D in low-resource settings, the value of partnering with research institutes in malaria-endemic countries, and how to establish mutually-beneficial research collaborations.
    Panel discussion John Ede, Ohaha Family Foundation, Nigeria
Treating malaria through health technology to "cut out" rural communities in Nigeria
 
      Dr Ademola Adelekan, Blue Gate Public Health Promotion Initiative, Nigeria
The ugly, the bad and the success of 2017 World Malaria Day commemoration at Orantan Community Ibadan Nigeria
 

12:30PM

LUNCH & NETWORKING

1:30PM CONCURRENT 8
  Investing in new tools & technologies/R&D: challenges for malaria elimination & eradication Are we staying on track with malaria elimination?Maintaining momentum and strategies for the last mile: Elimination/Eradication lessons learnt Partnering for strong malaria control & research & Universal Access: Providing services to people where rountine services do not reach Recent advances in severe malaria pathophysiology and treatment
    Chair: Prof Sir Brian Greenwood, London School of Hygiene and Tropical Medicine Chair: Dr Leanne Robinson, Burnet Institute Chair: Prof Arjen Dondorp
  Professor Michael Good, Griffith University Prof Sir Brian Greenwood, London School of Hygiene and Tropical Medicine Prof John Reeder, Director, Special Programme for Research & Training in Tropical Diseases, World Health Organisation Dr Haruhiko Isioka-Fluid Resuscitation in adult severe malaria: how dry can you go?
  Dr Ashley Birkett, Director, PATH Malaria Vaccine Initiative Professor Azra Ghani, Imperial Collegue London Prof Evelyn Ansah, University of Health & Allied Science, Ghana Dr Katherine Plewes-Protecting the kidney with paracetamol in severe falciparum malaria
  Dr Melissa Kapulu, CHMI, Kenya Medical Research Institute Professor Archie Clements, Director and Professor Research School of Population Health ANU College of Health and Medicine Prof Kamija Phiri, Director Training and Research Unit of Excellence, University of Malawi Dr Bridget Barber-The free haemoglobin, oxidative stress, acute kidney injury, pathway in knowlesi malaria
  Geoffrey Doiw, 60P Pharmaceuticals
Accelerating clinical development of antimalarials
Malaria elimination efforts in Sri Lanka Supporting volunteers in disease elimination: Lessons learnt from GMS. The role of volunteers in communities; Pressures to integrate at community level; how to sustain community involvement when cases are negligible; Communities and health promotion; role of volunteers Professor Nick Anstey-Concomitant bacteraemia in adult severe malaria
  Dr Michael Nissen, Director Scientific Affairs - GSK Dr Rainier Escalada, Advisor, Malaria Policy, Advocacy, and Capacity Building, PAHO
Malaria elimination efforts in Central and Latin America
Xianxian Lin, HPA
Reaching the most marginalized
Dr Stije Leopold-Contributors to metabolic acidosis in falciparum malaria
  Andrea Lukard, Executive Vice President, MMV Emeritus Professor Rose Leke, University of Yaounde, Camaroon 
Malaria in Africa comparison to other diseases eg polio
Thet Myo Tun, ARC
Meeting the needs of ethnic populations-health as a bridge to peace
Discussion/Q&A
    Dr Pedro Alonso, World Health Organisation
Priorities for maintaining momentum
Alistair Shaw, Raks Thai Foundation
The role of volunteers to support malaria elimination in Thailand
 
      John Ede, Ohaha Family Foundation, Nigeria
Treating malaria through health technology to "cut out" rural communities in Nigeria
 
      Dr Md Akramul Islam, BRAC Bangladesh
Scaling up health workforce in hard to reach areas of Chittagong: contributing to reduce severe malaria in Bangladesh
 
      Prof William Brieger, Health Systems Program of the Department of International Health, Johns Hopkins University
Mapping to adapt mass drug administration of ivermectin for lymphatic filariasis and onchercerciasis to malaria vector control
 
      Dr Aung Pyae Linn (Travel Grant Recipient)
Performance of village health volunteers regarding malaria control activities in Myanmar 
 
      Q&A Panel  
3:00PM AFTERNOON TEA & NETWORKING

3:30PM Chair: PROF JOHN REEDER, Special Programme for Research & Training in Tropical Diseases, World Health Organisation

4:00PM DR KAI PREUGSCHAT, Head of Co-Financing, Asia Development Bank
The Shifting Landscape for Financing Health

4:00PM PROF LENORE MANDERSON, Monash University
Social movements and community engagement

4:45PM PANEL DISCUSSION

5:30PM SHORT BREAK

5:45PM CONCURRENT 9
  Innovation for malaria surveillance   Antimalarial immune response - mechanisms and uses for diagnosis and surveillance Concurrent Session-Short Talks & Rapid Fire/Pitches/Gallery/Edutainment
  Chair: Dr Rowena Martin, Australian National University      
  Leandra Arndt, University of Technology Dresden
Novel magneto-optical method for malaria shows sustained potential in field tests in Papua New Guinea and Thailand
Dr George Rugarabamu, Policy Cures Research Ltd
Malaria research and development funding and pipeline
Michelle Boyle, Burnet Institute
Merozoite specific IgM is associated with protection from Plasmodium falciparum malaria in children and prevents RBC invasion via complement fixation
 
  Dr Mohammad Shafiul Alam, icddr,b
Field evaluation of point of care assays for quantifying Glucose-6-Phosphate Dehydrogenase activity
Dr Alistair McLean, Myanmar Oxford Clinical Research Unit
Malaria elimination in remote communities requires integration of malaria control activities into general health care: recent experience from Myanmar
Dr David Gurarie, Case Western Reserve University
Immune selection of malaria quasi-species: virulence, transmissibility and multiplicity of infection
 
  Dr Philippe Boeuf, Burnet Institute
A novel point-of-contact test for malaria serosurveillance
Dr Jamie Eliades, Population Services International
Engaging non-formal private providers in Myanmar to accelerate malaria elimination efforts
Dr Rhea Longley, Walter and Eliza Hall Institute
Development of serological markers for detecting recent exposure to Plasmodium vivax malaria
 
  Francois Rerolle, UCSF / MEI
Spatially optimizing malaria surveys for risk mapping and hotspot detection: adaptive sampling designs
Dr Sarah Charnaud, Walter and Eliza Hall Institute
Improving malaria elimination strategies with pharmacogenomics: tackling the unique problems posed by Plasmodium vivax
Dr Rob Commons, St Vincent's Hospital
Universal Radical Cure of malaria
 
  Sompob Saralamba, (AAF Nominee), Mahidol Oxford Tropical Medicine Research Unit Michael Kalnoky, PATH, USA
Leveraging modeled data to estimate the market size for tafenoquine and glucose-6-phosphate dehydrogenase deficiency diagnostics to support decision-making on service delivery models
Dr Wang Nguitragool (AAF Nominee), Mahidol University  
  Benjamin Palafox, London School of Hygiene & Tropical Medicine
Opportunities and challenges to strengthen disease surveillance to support malaria elimination in the Philippines
Germana Bancone, Shoklo Malaria Research Unit
Unit: Validation of G6PD Biosensors for vivax malaria elimination
   
6:30PM Q&A TO END MALARIA COCKTAIL FUNCTION
Facilitator: Norman Swan